Literature DB >> 19694545

Rotavirus and reovirus modulation of the interferon response.

Barbara Sherry1.   

Abstract

The mammalian reoviruses and rotaviruses have evolved specific mechanisms to evade the Type I interferon (IFN) antiviral response. Rotavirus likely represses the IFN response by at least 4 mechanisms. First, the rotavirus protein NSP1, most likely functioning as an E3 ligase, can induce proteasome-dependent degradation of the transcription factors IRF3, IRF5, and IRF7 to prevent their induction of IFN. Second, NSP1 can induce proteasome-dependent degradation of the ubiquitin ligase complex protein beta-TrCP, resulting in stabilization of I kappaB and concomitant failure of virus to activate NF-kappaB for induction of IFN. Third, rotavirus may sequester NF-kappaB in viroplasms. And fourth, rotavirus can prevent STAT1 and STAT2 nuclear translocation. The predominant mechanism for rotavirus inhibition of the IFN response is likely both rotavirus strain-specific and cell type-specific. The mammalian reoviruses also display strain-specific differences in their modulation of the IFN response. Reovirus activates RIG-I and IPS-1 for phosphorylation of IRF3. Reovirus-induced activation of MDA5 also participates in induction if IFN-beta, perhaps through activation of NF-kappaB. Reovirus likely inhibits the IFN response by at least 3 virus strain-specific mechanisms. First, the reovirus mu2 protein can induce an unusual nuclear accumulation of IRF9 and repress IFN-stimulated gene (ISG) expression, most likely by disrupting IRF9 function as part of the heterotrimeric transcription factor complex, ISGF3. Second, the reovirus sigma 3 protein can bind dsRNA and prevent activation of the latent antiviral effector protein PKR. And third, genetic approaches have identified the reovirus lambda 2 and sigma 2 proteins in virus strain-specific modulation of the IFN response, but the significance remains unclear. In sum, members of the family Reoviridae have evolved a variety of mechanisms to subvert the host's innate protective response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19694545      PMCID: PMC2956631          DOI: 10.1089/jir.2009.0072

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  81 in total

Review 1.  Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures.

Authors:  Richard E Randall; Stephen Goodbourn
Journal:  J Gen Virol       Date:  2008-01       Impact factor: 3.891

Review 2.  Rotavirus vaccines: an overview.

Authors:  Penelope H Dennehy
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

3.  Reovirus apoptosis and virulence are regulated by host cell membrane penetration efficiency.

Authors:  Pranav Danthi; Takeshi Kobayashi; Geoffrey H Holm; Mark W Hansberger; Ty W Abel; Terence S Dermody
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

4.  Role for herpes simplex virus 1 ICP27 in the inhibition of type I interferon signaling.

Authors:  Karen E Johnson; Byeongwoon Song; David M Knipe
Journal:  Virology       Date:  2008-02-14       Impact factor: 3.616

5.  Select paramyxoviral V proteins inhibit IRF3 activation by acting as alternative substrates for inhibitor of kappaB kinase epsilon (IKKe)/TBK1.

Authors:  Lenette L Lu; Mamta Puri; Curt M Horvath; Ganes C Sen
Journal:  J Biol Chem       Date:  2008-03-24       Impact factor: 5.157

6.  The NY-1 hantavirus Gn cytoplasmic tail coprecipitates TRAF3 and inhibits cellular interferon responses by disrupting TBK1-TRAF3 complex formation.

Authors:  Peter J Alff; Nandini Sen; Elena Gorbunova; Irina N Gavrilovskaya; Erich R Mackow
Journal:  J Virol       Date:  2008-07-09       Impact factor: 5.103

7.  Role of interferon in homologous and heterologous rotavirus infection in the intestines and extraintestinal organs of suckling mice.

Authors:  N Feng; B Kim; M Fenaux; H Nguyen; P Vo; M B Omary; H B Greenberg
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103

8.  Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity.

Authors:  Yueh-Ming Loo; Jamie Fornek; Nanette Crochet; Gagan Bajwa; Olivia Perwitasari; Luis Martinez-Sobrido; Shizuo Akira; Michelle A Gill; Adolfo García-Sastre; Michael G Katze; Michael Gale
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

9.  Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5.

Authors:  Hiroki Kato; Osamu Takeuchi; Eriko Mikamo-Satoh; Reiko Hirai; Tomoji Kawai; Kazufumi Matsushita; Akane Hiiragi; Terence S Dermody; Takashi Fujita; Shizuo Akira
Journal:  J Exp Med       Date:  2008-07-07       Impact factor: 14.307

Review 10.  Interferons at age 50: past, current and future impact on biomedicine.

Authors:  Ernest C Borden; Ganes C Sen; Gilles Uze; Robert H Silverman; Richard M Ransohoff; Graham R Foster; George R Stark
Journal:  Nat Rev Drug Discov       Date:  2007-12       Impact factor: 84.694

View more
  42 in total

1.  Cooperative roles of fish protein kinase containing Z-DNA binding domains and double-stranded RNA-dependent protein kinase in interferon-mediated antiviral response.

Authors:  Ting-Kai Liu; Yi-Bing Zhang; Ying Liu; Fan Sun; Jian-Fang Gui
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  Rotavirus NSP1 mediates degradation of interferon regulatory factors through targeting of the dimerization domain.

Authors:  Michelle M Arnold; Mario Barro; John T Patton
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

3.  Rotavirus replication requires a functional proteasome for effective assembly of viroplasms.

Authors:  R Contin; F Arnoldi; M Mano; O R Burrone
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

4.  Type I interferon signaling limits reoviral tropism within the brain and prevents lethal systemic infection.

Authors:  Kalen R Dionne; John M Galvin; Stephanie A Schittone; Penny Clarke; Kenneth L Tyler
Journal:  J Neurovirol       Date:  2011-06-14       Impact factor: 2.643

5.  Inhibition of cellular proteasome activities mediates HBX-independent hepatitis B virus replication in vivo.

Authors:  Zhensheng Zhang; Eun Sun; Jing-hsiung James Ou; T Jake Liang
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

Review 6.  Cytokine-induced tumor suppressors: a GRIM story.

Authors:  Dhan V Kalvakolanu; Shreeram C Nallar; Sudhakar Kalakonda
Journal:  Cytokine       Date:  2010-04-10       Impact factor: 3.861

7.  Virus-induced autophagic degradation of STAT2 as a mechanism for interferon signaling blockade.

Authors:  Miguel Avia; José M Rojas; Lisa Miorin; Elena Pascual; Piet A Van Rijn; Verónica Martín; Adolfo García-Sastre; Noemí Sevilla
Journal:  EMBO Rep       Date:  2019-10-11       Impact factor: 8.807

8.  The effect of bovine rotavirus and its nonstructural protein 4 on ER stress-mediated apoptosis in HeLa and HT-29 cells.

Authors:  Zahra Goodarzi; Hoorieh Soleimanjahi; Ehsan Arefian; Esmaeil Saberfar
Journal:  Tumour Biol       Date:  2015-10-01

9.  Refractoriness of interferon-beta signaling through NOD1 pathway in mouse respiratory epithelial cells using the anticancer xanthone compound.

Authors:  Zaifang Yu; Jarrod D Predina; Guanjun Cheng
Journal:  World J Biol Chem       Date:  2013-05-26

10.  Inhibition of antiviral innate immunity by birnavirus VP3 protein via blockage of viral double-stranded RNA binding to the host cytoplasmic RNA detector MDA5.

Authors:  Chengjin Ye; Lu Jia; Yanting Sun; Boli Hu; Lun Wang; Xingmeng Lu; Jiyong Zhou
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.